Midatech to pump £10m into gold-nanoparticle drug delivery tech
This article was originally published in Clinica
Nanomedicines firm Midatech has raised £10m ($16m) in an equity financing round led by Ippon Capital. The Geneva-based VC firm committed £7.6m while the remainder came from existing investors. The financing is a quick feather in the cap of new CEO Dr Jim Philips, who joined Midatech in September.